Many entrepreneurs have focused on investing in the stock market. The entrepreneurs are making huge profits from their investments when the stocks they have invested in increase in value. For that reason, they need to work with stock experts to help them in knowing the right shares to invest in so that they can realize profits and avoid loses. Sahm Adrangi is one of the stock experts who has been helping new entrepreneurs as well as established stock traders with tips on which stocks to invest in and avoid.
Sahm Adrangi has been in the stock industry for a long time. He founded one of the leading investment management companies that have been helping people with stock market tips by the name Kerrisdale Capital Management. The company was launched in 2009, and it has grown significantly to an over $150 million investment management firm. The company leads in research and works hard to ensure that they publish beneficial information about share values of various companies listed in the stock market. Sahm and his company have exposed many companies that investors should avoid their shares like Sage Therapeutics, China Marine Food Group, and China-Biotics.
Due to hard work and research, Adrangi gives adverse reports on companies that are doing well in the stock market. Most of the companies that he focuses on have high share prices which attract many investors. With his research and support from his team, Sahm Adrangi has shared reports on some companies such as St Joe Company, Proteostasis Therapeutics, Eastman Kodak Company, and QuinStreet Inc. St Joe Company is a property development company based in Florida which according to Sahm’s research is overvalued, and its shares’ value will drop soon as a result of new SEC rules.
When it comes to Proteostasis Therapeutics, Sahm Adrangi has given a short position on the company’s stocks. The company has released a drug that targets to cure cystic fibrosis but the drug is ineffective, and it will affect the company’s shares’ value in the market. QuinStreet Inc. is another company that has flawed business models, and Adrangi believes that the cost of its shares will go down soon.